Health Outcomes Strategies, GmbH, Basel

By knowing and integrating the perspectives of our customers, we balance and mediate their perceptions of value - early and throughout product development.

Mission Statement
The International Society for Pharmacoeconomics and Outcomes Research is an international organization promoting the science of pharmacoeconomics and health outcomes research.
The International Society is organized to act as a scientific leader relevant to research in pharmacoeconomics, health outcomes assessment, and related issues of public policy.
The International Society represents healthcare researchers and practitioners including pharmacists, physicians, economists, nurses and researchers from academia, pharmaceutical industry, government, managed care, health research organizations, and purchasers of healthcare. The mission of the International Society for Pharmacoeconomics and Outcomes Research is to translate pharmacoeconomics and outcomes research into practice to ensure that society allocates scarce healthcare resources wisely, fairly, and efficiently.

Health technology assessment (HTA) plays an essential role in modern health care by supporting evidence based decision making in health care policy and practice. There is a vibrant and growing community around the world of those who develop and use HTA. HTAi's mission is to support the growth of that community by providing a global forum for the exchange of information, methods, and expertise.

BioValley Basel is a non-profit organisation. It is the Swiss pillar of the trinational BioValley Initiative. The association’s focus is to support companies and institutions by providing access to the member’s network and its broad range of knowledge and expertise in the field of Life Sciences.

Basel is a major center for pharmaceuticals, chemical, and modern biotechnology industries. Over 900 life sciences companies are present in the BioValley region, which constitute about 40% of the world’s life sciences industry.